keyword
https://read.qxmd.com/read/38514467/antibiotic-treatment-modestly-reduces-protection-against-mycobacterium-tuberculosis-reinfection-in-macaques
#21
JOURNAL ARTICLE
Sharie Keanne Ganchua, Pauline Maiello, Michael Chao, Forrest Hopkins, Douaa Mugahid, Philana Ling Lin, Sarah M Fortune, JoAnne L Flynn
Concomitant immunity is generally defined as an ongoing infection providing protection against reinfection . Its role in prevention of tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is supported by epidemiological evidence in humans as well as experimental evidence in mice and non-human primates (NHPs). Whether the presence of live Mtb, rather than simply persistent antigen, is necessary for concomitant immunity in TB is still unclear. Here, we investigated whether live Mtb plays a measurable role in control of secondary Mtb infection...
March 22, 2024: Infection and Immunity
https://read.qxmd.com/read/38505920/employing-multicolor-melting-curve-analysis-to-rapidly-identify-non-tuberculous-mycobacteria-in-patients-with-bronchiectasis-a-study-from-a-pulmonary-hospital-in-the-fuzhou-district-of-china-2018-2022
#22
JOURNAL ARTICLE
Mintao Zheng, Xinchao Chen, Qiaoqian Chen, Xiaohong Chen, Mingxiang Huang
Non-tuberculous mycobacteria (NTM) infection is common in bronchiectasis, with rising incidence globally. However, investigation into NTM in bronchiectasis patients in China remains relatively limited. This work aimed to identify and understand the features of NTM in bronchiectasis patient in Fuzhou district of China. The pulmonary samples were collected from 281 bronchiectasis patients with suspected NTM infection in Fuzhou, 2018-2022. MPB64 antigen detection was employed for the preliminary evaluation of NTM...
2024: Critical Reviews in Immunology
https://read.qxmd.com/read/38505086/a-narrative-review-of-the-controversy-on-the-risk-of-mycobacterial-infections-with-immune-checkpoint-inhibitor-use-does-goldilocks-have-the-answer
#23
REVIEW
Akshara Vaddi, Holly J Hulsebus, Emily L O'Neill, Vijaya Knight, Edward D Chan
BACKGROUND AND OBJECTIVE: Immune checkpoint inhibitors (ICIs) have revolutionized oncologic treatment. Whether ICIs increase susceptibility to or provide protection against mycobacterial infections remains controversial. The objective of this narrative review is to summarize the literature on the link between ICI use and mycobacterial infections-tuberculosis and non-tuberculous mycobacterial (NTM) infections-and to critically discuss evidence linking ICIs with mycobacterial infections, the possible confounders, and, if indeed the ICIs predispose to such infections, the potential mechanisms of how this may occur...
February 29, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38500280/interferon-upregulation-associates-with-insulin-resistance-in-humans
#24
JOURNAL ARTICLE
Maria M Adeva-Andany, Natalia Carneiro-Freire, Elvira Castro-Quintela, Eva Ameneiros-Rodriguez, Lucia Adeva-Contreras, Carlos Fernandez-Fernandez
In humans, insulin resistance is a physiological response to infections developed to supply sufficient energy to the activated immune system. This metabolic adaptation facilitates the immune response but usually persists after the recovery period of the infection and predisposes the hosts to type 2 diabetes and vascular injury. In patients with diabetes, superimposed insulin resistance worsens metabolic control and promotes diabetic ketoacidosis. Pathogenic mechanisms underlying insulin resistance during microbial invasions remain to be fully defined...
March 18, 2024: Current Diabetes Reviews
https://read.qxmd.com/read/38498580/transposon-sequencing-reveals-metabolic-pathways-essential-for-mycobacterium-tuberculosis-infection
#25
JOURNAL ARTICLE
Alisha M Block, Parker C Wiegert, Sarah B Namugenyi, Anna D Tischler
New drugs are needed to shorten and simplify treatment of tuberculosis caused by Mycobacterium tuberculosis. Metabolic pathways that M. tuberculosis requires for growth or survival during infection represent potential targets for anti-tubercular drug development. Genes and metabolic pathways essential for M. tuberculosis growth in standard laboratory culture conditions have been defined by genome-wide genetic screens. However, whether M. tuberculosis requires these essential genes during infection has not been comprehensively explored because mutant strains cannot be generated using standard methods...
March 18, 2024: PLoS Pathogens
https://read.qxmd.com/read/38496518/rare-variable-m-tuberculosis-antigens-induce-predominant-th17-responses-in-human-infection
#26
Paul Ogongo, Liya Wassie, Anthony Tran, Devin Columbus, Lisa Sharling, Gregory Ouma, Samuel Gurrion Ouma, Kidist Bobosha, Cecilia S Lindestam Arlehamn, Neel R Gandhi, Sara C Auld, Jyothi Rengarajan, Cheryl L Day, John D Altman, Henry M Blumberg, Joel D Ernst
CD4 T cells are essential for immunity to M. tuberculosis ( Mtb ), and emerging evidence indicates that IL-17-producing Th17 cells contribute to immunity to Mtb . While identifying protective T cell effector functions is important for TB vaccine design, T cell antigen specificity is also likely to be important. To identify antigens that induce protective immunity, we reasoned that as in other pathogens, effective immune recognition drives sequence diversity in individual Mtb antigens. We previously identified Mtb genes under evolutionary diversifying selection pressure whose products we term Rare Variable Mtb Antigens (RVMA)...
March 6, 2024: bioRxiv
https://read.qxmd.com/read/38496444/myc-dysregulation-in-activated-macrophages-initiates-iron-mediated-lipid-peroxidation-that-fuels-type-i-interferon-and-compromises-tb-resistance
#27
Shivraj M Yabaji, Vadim Zhernovkov, Prasanna Babu Araveti, Suruchi Lata, Oleksii S Rukhlenko, Salam Al Abdullatif, Yuriy Alekseev, Qicheng Ma, Gargi Dayama, Nelson C Lau, William R Bishai, Nicholas A Crossland, Joshua D Campbell, Boris N Kholodenko, Alexander A Gimelbrant, Lester Kobzik, Igor Kramnik
A quarter of human population is infected with Mycobacterium tuberculosis , but less than 10% of those infected develop clinical, mostly pulmonary, TB. To dissect mechanisms of susceptibility in immunocompetent individuals, we developed a genetically defined sst1 -susceptible mouse model that uniquely reproduces a defining feature of human TB: development of necrotic lung lesions after infection with virulent Mtb. In this study, we explored the connectivity of the sst1 -regulated pathways during prolonged macrophage activation with TNF...
March 10, 2024: bioRxiv
https://read.qxmd.com/read/38478483/the-trajectories-of-cd4-t-lymphocytes-over-time-in-patients-who-have-defaulted-on-treatment-for-tuberculosis-in-a-cohort-of-people-living-with-hiv-recife-pe
#28
JOURNAL ARTICLE
Rossana Cunha, Demócrito de B M Filho, Maria de Fátima P M Albuquerque, Heloísa R Lacerda, George T N Diniz, Ulisses R Montarroyos, Laura C Rodrigues, Líbia Cristina R Vilela Moura, Ricardo A A Ximenes
BACKGROUND: The CD4 T lymphocyte count in people living with HIV (PLHIV) is a predictor for the progression of the disease (AIDS), survival and response to antiretroviral treatment (ART). A CD4 T lymphocyte count of less than 200 cells/mm3 is indicative of a greater risk for the onset of opportunistic diseases and death. Defaulting on treatment for tuberculosis (TB) may impact immune recovery in PLHIV who are taking ART. The aim of this study was to investigate an association of the CD4 lymphocyte with TB treatment Trajectory and with death...
2024: PloS One
https://read.qxmd.com/read/38476473/identification-and-validation-of-genes-related-to-macrophage-polarization-and-cell-death-modes-under-mycobacterium-tuberculosis-infection
#29
JOURNAL ARTICLE
Zisha Yang, Jiajun Wang, Jiang Pi, Di Hu, Junfa Xu, Yi Zhao, Yan Wang
PURPOSE: To investigate the correlation between M1/M2 macrophages (M1/M2 Mφ) and cell death mode under Mycobacterium tuberculosis (Mtb) infection. METHODS: Raw gene expression profiles were collected from the Gene Expression Omnibus (GEO) database. Genes related to different cell death modes were collected from the KEGG, FerrDb and GSEA databases. The differentially expressed genes (DEGs) of the gene expression profiles were identified using the limma package in R...
2024: Journal of Inflammation Research
https://read.qxmd.com/read/38474145/human-macrophages-activate-bystander-neutrophils-metabolism-and-effector-functions-when-challenged-with-mycobacterium-tuberculosis
#30
JOURNAL ARTICLE
Dearbhla M Murphy, Anastasija Walsh, Laura Stein, Andreea Petrasca, Donal J Cox, Kevin Brown, Emily Duffin, Gráinne Jameson, Sarah A Connolly, Fiona O'Connell, Jacintha O'Sullivan, Sharee A Basdeo, Joseph Keane, James J Phelan
Neutrophils are dynamic cells, playing a critical role in pathogen clearance; however, neutrophil infiltration into the tissue can act as a double-edged sword. They are one of the primary sources of excessive inflammation during infection, which has been observed in many infectious diseases including pneumonia and active tuberculosis (TB). Neutrophil function is influenced by interactions with other immune cells within the inflammatory lung milieu; however, how these interactions affect neutrophil function is unclear...
March 1, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38470107/activation-of-the-lysosomal-damage-response-and-selective-autophagy-the-coordinated-actions-of-galectins-trim-proteins-and-cgas-sting1-in-providing-immunity-against-mycobacterium-tuberculosis
#31
REVIEW
Asrar Ahmad Malik, Mohd Shariq, Javaid Ahmad Sheikh, Sheeba Zarin, Yashika Ahuja, Haleema Fayaz, Anwar Alam, Nasreen Z Ehtesham, Seyed E Hasnain
Autophagy is a crucial immune defense mechanism that controls the survival and pathogenesis of M. tb by maintaining cell physiology during stress and pathogen attack. The E3-Ub ligases (PRKN, SMURF1, and NEDD4) and autophagy receptors (SQSTM1, TAX1BP1, CALCOCO2, OPTN, and NBR1) play key roles in this process. Galectins (LGALSs), which bind to sugars and are involved in identifying damaged cell membranes caused by intracellular pathogens such as M. tb , are essential. These include LGALS3, LGALS8, and LGALS9, which respond to endomembrane damage and regulate endomembrane damage caused by toxic chemicals, protein aggregates, and intracellular pathogens, including M...
March 12, 2024: Critical Reviews in Microbiology
https://read.qxmd.com/read/38461350/antigen-identification-strategies-and-preclinical-evaluation-models-for-advancing-tuberculosis-vaccine-development
#32
REVIEW
Saurabh Chugh, Ritika Kar Bahal, Rohan Dhiman, Ramandeep Singh
In its myriad devastating forms, Tuberculosis (TB) has existed for centuries, and humanity is still affected by it. Mycobacterium tuberculosis (M. tuberculosis), the causative agent of TB, was the foremost killer among infectious agents until the COVID-19 pandemic. One of the key healthcare strategies available to reduce the risk of TB is immunization with bacilli Calmette-Guerin (BCG). Although BCG has been widely used to protect against TB, reports show that BCG confers highly variable efficacy (0-80%) against adult pulmonary TB...
March 9, 2024: NPJ Vaccines
https://read.qxmd.com/read/38461088/-severe-complications-of-systemic-treatment-in-thoracic-oncology
#33
REVIEW
T Berghmans, M Brandão, M Ilzkovitz, A-P Meert
Primary thoracic cancers affect a large number of patients, mainly those with lung cancer and to a lesser extent those with pleural mesothelioma and thymic tumours. Given their frequency and associated comorbidities, in patients whose mean age is high, these diseases are associated with multiple complications. This article, the last of a series dedicated to emergencies in onco-haematological patients, aims to present a clinical picture of the severe complications (side effects, immune-related adverse events) associated with systemic treatments, excluding infections and respiratory emergencies, with which general practitioners and specialists can be confronted...
March 8, 2024: Revue des Maladies Respiratoires
https://read.qxmd.com/read/38458134/prevalence-of-infectious-diseases-immunity-to-vaccine-preventable-diseases-and-chronic-medical-conditions-among-ukrainian-refugees-in-germany-a-cross-sectional-study-from-the-german-network-university-medicine-num
#34
JOURNAL ARTICLE
Folke Brinkmann, Anette Friedrichs, Georg Mn Behrens, Pia Behrens, Reinhard Berner, Amke Caliebe, Claudia M Denkinger, Katharina Giesbrecht, Alexander Gussew, Anna Theresa Hoffmann, Leonhard Hojenski, Olga Hovardovska, Alexandra Dopfer-Jablonka, Achim J Kaasch, Robin Kobbe, Monika Kraus, Andreas Lindner, Christoph Maier, Lazar Mitrov, Matthias Nauck, Susana Nunes de Miranda, Margarete Scherer, Yvonne Schmiedel, Dana Stahl, Nina Timmesfeld, Nicole Toepfner, Janne Vehreschild, Walter A Wohlgemuth, Astrid Petersmann, Maria J G T Vehreschild
BACKGROUND: Vulnerability to infectious diseases in refugees is dependent on country of origin, flight routes, and conditions. Information on specific medical needs of different groups of refugees is lacking. We assessed the prevalence of infectious diseases, immunity to vaccine-preventable diseases, and chronic medical conditions in children, adolescents, and adult refugees from Ukraine who arrived in Germany in 2022. METHODS: Using different media, we recruited Ukrainian refugees at 13 sites between 9-12/2022...
February 16, 2024: Journal of Infection and Public Health
https://read.qxmd.com/read/38452145/multiple-genetic-loci-influence-vaccine-induced-protection-against-mycobacterium-tuberculosis-in-genetically-diverse-mice
#35
JOURNAL ARTICLE
Sherry L Kurtz, Richard E Baker, Frederick J Boehm, Chelsea C Lehman, Lara R Mittereder, Hamda Khan, Amy P Rossi, Daniel M Gatti, Gillian Beamer, Christopher M Sassetti, Karen L Elkins
Mycobacterium tuberculosis (M.tb.) infection leads to over 1.5 million deaths annually, despite widespread vaccination with BCG at birth. Causes for the ongoing tuberculosis endemic are complex and include the failure of BCG to protect many against progressive pulmonary disease. Host genetics is one of the known factors implicated in susceptibility to primary tuberculosis, but less is known about the role that host genetics plays in controlling host responses to vaccination against M.tb. Here, we addressed this gap by utilizing Diversity Outbred (DO) mice as a small animal model to query genetic drivers of vaccine-induced protection against M...
March 7, 2024: PLoS Pathogens
https://read.qxmd.com/read/38448182/-advances-in-the-co-signal-molecular-function-of-mtb-specific-t-lymphocytes
#36
JOURNAL ARTICLE
J Tong, S S Li, Y Pang, M Q Gao
Costimulatory and co-inhibitory receptors on T lymphocytes play an essential role in the immune response. There is increasing evidence that the expression of co-signal molecules on T cells is altered in infection, tumor, autoimmunity, and other diseases, and that intervention of co-signal molecules can be used in the immunotherapy. This paper reviewed the costimulatory and coinhibitory receptors on Mtb -specific T lymphocytes and further explained the mechanism of co-signal molecules in the progression of tuberculosis, to provide a reference for future research and clinical application...
March 12, 2024: Chinese Journal of Tuberculosis and Respiratory Diseases
https://read.qxmd.com/read/38448169/-clinical-features-and-prognostic-analysis-of-checkpoint-inhibitor-pneumonitis-in-patients-with-non-small-cell-lung-cancer
#37
JOURNAL ARTICLE
R X Chen, X N Liu, Y Xu, Y J Shi, M Q Wang, C Shao, H Huang, K Xu, M Z Wang, Z J Xu
Objective: To describe the clinical characteristics of patients with non-small cell lung cancer (NSCLC) who developed checkpoint inhibitor pneumonitis (CIP) and to explore potential prognostic factors. Methods: NSCLC patients who were complicated with CIP after immune checkpoint inhibitors (ICIs) therapy in our institute were enrolled in this study from 1 July 2018 to 30 November 2022. Clinical data of NSCLC-CIP patients were collected, including clinical and radiological features and their outcomes. Results: Among the 70 enrolled NSCLC-CIP patients, there were 57 males (81%) and 13 females (19%)...
March 12, 2024: Chinese Journal of Tuberculosis and Respiratory Diseases
https://read.qxmd.com/read/38442242/bioorthogonal-metabolic-labeling-of-the-virulence-factor-phenolic-glycolipid-in-mycobacteria
#38
JOURNAL ARTICLE
Lindsay E Guzmán, C J Cambier, Tan-Yun Cheng, Kubra F Naqvi, Michael U Shiloh, D Branch Moody, Carolyn R Bertozzi
Surface lipids on pathogenic mycobacteria modulate infection outcomes by regulating host immune responses. Phenolic glycolipid (PGL) is a host-modulating surface lipid that varies among clinical Mycobacterium tuberculosis strains. PGL is also found in Mycobacterium marinum , where it promotes infection of zebrafish through effects on the innate immune system. Given the important role this lipid plays in the host-pathogen relationship, tools for profiling its abundance, spatial distribution, and dynamics are needed...
March 5, 2024: ACS Chemical Biology
https://read.qxmd.com/read/38433842/whole-blood-rna-signatures-in-tuberculosis-patients-receiving-h56-ic31-vaccine-as-adjunctive-therapy
#39
JOURNAL ARTICLE
Noelia Alonso-Rodríguez, Eleonora Vianello, Suzanne van Veen, Synne Jenum, Kristian Tonby, Rosalie van Riessen, Xiaoran Lai, Rasmus Mortensen, Tom H M Ottenhoff, Anne Ma Dyrhol-Riise
INTRODUCTION: Therapeutic vaccination in tuberculosis (TB) represents a Host Directed Therapy strategy which enhances immune responses in order to improve clinical outcomes and shorten TB treatment. Previously, we have shown that the subunit H56:IC31 vaccine induced both humoral and cellular immune responses when administered to TB patients adjunctive to standard TB treatment (TBCOX2 study, NCT02503839). Here we present the longitudinal whole blood gene expression patterns in H56:IC31 vaccinated TB patients compared to controls receiving standard TB treatment only...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38425601/pulmonary-tuberculosis-following-immune-checkpoint-inhibitor-treatment-for-recurrent-maxillary-squamous-cell-carcinoma
#40
Shogo Kikuta, Yushi Abe, Katsumi Shinozaki, Naoko Seki, Jingo Kusukawa
Immune checkpoint inhibitors (ICIs) like nivolumab and pembrolizumab are effective treatments for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). However, they can lead to immune-related adverse events (irAEs) and tuberculosis (TB) reactivation. We present a case of a 79-year-old male with recurrent maxillary squamous cell carcinoma treated with pembrolizumab, cisplatin, and 5-fluorouracil. The patient developed a fever, and pulmonary TB development was confirmed. Prolonged TB treatment was required, and ICI treatment was discontinued...
January 2024: Curēus
keyword
keyword
164987
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.